Metastatic colorectal carcinoma and kidney tumors: a report of four cases

被引:4
作者
Melichar, Bohuslav [1 ,2 ,6 ]
Moravek, Petr [3 ]
Ferko, Alexander [4 ]
Podhola, Miroslav [5 ]
机构
[1] Palacky Univ, Sch Med, Teaching Hosp, Dept Oncol, Olomouc 77520, Czech Republic
[2] Charles Univ Prague, Sch Med, Teaching Hosp, Dept Oncol & Radiotherapy, Hradec Kralove, Czech Republic
[3] Charles Univ Prague, Sch Med, Teaching Hosp, Dept Urol, Hradec Kralove, Czech Republic
[4] Charles Univ Prague, Sch Med, Teaching Hosp, Dept Surg, Hradec Kralove, Czech Republic
[5] Charles Univ Prague, Sch Med, Teaching Hosp, Dept Pathol, Hradec Kralove, Czech Republic
[6] Charles Univ Prague, Sch Med, Teaching Hosp, Inst Expt Neurosurg, Hradec Kralove, Czech Republic
关键词
colorectal carcinoma; renal cell carcinoma; nephrectomy; RENAL-CELL CARCINOMA; PRIMARY MALIGNANCIES; CANCER; NEPHRECTOMY; FLUOROURACIL; BEVACIZUMAB; LEUCOVORIN; OXALIPLATIN; IRINOTECAN; REGRESSION;
D O I
10.1177/030089161009600318
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims and background. The prognosis of patients with metastatic colorectal carcinoma (CRC) has improved substantially over the last two decades. Longer patient survival comes at a price of more complications, including second primary neoplasms and metastases at unusual sites. Method. Retrospective chart review. Results. We present 4 patients with metastatic CRC who developed kidney tumors. In 2 cases, partial nephrectomy or nephrectomy was performed for second primary renal cell carcinoma. The patients survived 2.5 and more than 6 years after kidney surgery. In the other 2 patients the kidney tumors were diagnosed as CRC metastases, histologically verified in one case; these two patients died within two years of diagnosis of kidney involvement. Conclusion. The diagnostic approach to kidney tumors in CRC patients should include a biopsy because only patients with primary renal cell carcinoma and selected patients with metastatic CRC benefit from nephrectomy. Free full text available at www.turnorionline.it
引用
收藏
页码:483 / 486
页数:4
相关论文
共 22 条
  • [1] Colon cancer with isolated metastasis to the kidney at the time of initial diagnosis
    Gorkem Aksu
    Merdan Fayda
    Burak Sakar
    Yersu Kapran
    [J]. International Journal of Gastrointestinal Cancer, 2003, 34 (2-3): : 73 - 77
  • [2] Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer
    Banks, RE
    Tirukonda, P
    Taylor, C
    Hornigold, N
    Astuti, D
    Cohen, D
    Maher, ER
    Stanley, AJ
    Harnden, P
    Joyce, A
    Knowles, M
    Selby, PJ
    [J]. CANCER RESEARCH, 2006, 66 (04) : 2000 - 2011
  • [3] Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study
    Beisland, C
    Talleraas, O
    Bakke, A
    Norstein, J
    [J]. BJU INTERNATIONAL, 2006, 97 (04) : 698 - 702
  • [4] Brambilla E, 2007, Can J Urol, V14, P3649
  • [5] Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
    Escudier, Bernard
    Pluzanska, Anna
    Koralewski, Piotr
    Ravaud, Alain
    Bracarda, Sergio
    Szczylik, Cezary
    Chevreau, Christine
    Filipek, Marek
    Melichar, Bohuslav
    Bajetta, Emilio
    Gorbunova, Vera
    Bay, Jacques-Olivier
    Bodrogi, Istvan
    Jagiello-Gruszfeld, Agnieszka
    Moore, Nicola
    [J]. LANCET, 2007, 370 (9605) : 2103 - 2111
  • [6] Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer
    Flanigan, RC
    Salmon, SE
    Blumenstein, BA
    Bearman, SI
    Roy, V
    McGrath, PC
    Caton, JR
    Munshi, N
    Crawford, ED
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) : 1655 - 1659
  • [7] Furak Jozsef, 2008, Interact Cardiovasc Thorac Surg, V7, P50, DOI 10.1510/icvts.2007.160846
  • [8] Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
    Giantonio, Bruce J.
    Catalano, Paul J.
    Meropol, Neal J.
    O'Dwyer, Peter J.
    Mitchell, Edith P.
    Alberts, Steven R.
    Schwartz, Michael A.
    Benson, Al B., III
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) : 1539 - 1544
  • [9] Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
    Grothey, A
    Sargent, D
    Goldberg, RM
    Schmoll, HJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1209 - 1214
  • [10] Hoar S K, 1985, Natl Cancer Inst Monogr, V68, P49